Preserved white matter in unmedicated pediatric bipolar disorder

Ana Maria A Teixeira1, Ana Kleinman2, Marcus Zanetti3

  • 1Bipolar Research Program, Department of Psychiatry, University of São Paulo School of Medicine, São Paulo, Brazil; Laboratory of Psychiatric Neuroimaging, Department of Psychiatry, University of São Paulo School of Medicine, São Paulo, Brazil; Center for the Support of Research in Applied Neuroscience, University of São Paulo, São Paulo, Brazil.

Neuroscience Letters
|July 15, 2014
PubMed

Insights

This study found no white matter (WM) microstructural differences in pediatric bipolar disorder (BD) patients or their healthy offspring compared to controls. These findings suggest WM alterations may not be an early vulnerability marker in this specific pediatric population.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Developmental Psychology

Background:

  • White matter (WM) abnormalities are reported in bipolar disorder (BD) and relatives, suggesting a potential vulnerability marker.
  • Previous research often involved older subjects, medicated patients, or offspring with other psychiatric diagnoses.

Purpose of the Study:

  • To investigate WM microstructure in pediatric, unmedicated BD patients and healthy offspring of BD parents.
  • To determine if WM alterations are present in early stages of BD development.

Main Methods:

  • Utilized 3T Diffusion Tensor Magnetic Resonance Imaging (DT-MRI) on 18 pediatric BD patients, 18 healthy offspring, and 20 healthy controls.
  • Employed tract-based spatial statistics to analyze fractional anisotropy and diffusivity measures of WM microstructure.

Main Results:

  • No significant differences in WM microstructure were found between the pediatric BD patients, healthy offspring, and healthy control groups.
  • This contrasts with findings in older populations or those with different clinical profiles.

Conclusions:

  • WM microstructure differences may not be an early indicator of vulnerability for bipolar disorder in pediatric, unmedicated populations.
  • Understanding disease ontogeny and brain development is crucial for identifying early vulnerability markers.

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
1.4K
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
791
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K